ABSTRACT
Over the past 20 years there has been a marked increase in the prevalence of substance use disorders (SUDs) among women of reproductive years. The main drugs used in pregnancy are nicotine, alcohol, cannabis, cocaine, amphetamines and opioids. Given the medical, obstetric and psychosocial complications associated with the use of drugs, pregnant drug users are clearly a vulnerable group. Despite the increasing numbers of pregnant women with SUDs, research on treatment is limited.1
